Brain tumor acidification using drugs simultaneously targeting multiple pH regulatory mechanisms
- 7 August 2019
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 144 (3) , 453-462
Abstract
Introduction Non-invasively distinguishing aggressive from non-aggressive brain tumors is an important clinical challenge. Intracellular pH (pHi) regulation is essential for normal cell function and is normally maintained within a narrow range. Cancer cells are characterized by a reversed intracellular to extracellular pH gradient, compared to healthy cells, that is maintained by several distinct mechanisms. Previous studies have demonstrated acute pH modulation in glioblastoma detectable by chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) after blocking individual pH regulatory mechanisms. The purpose of the current study was to simultaneously block five pH regulatory mechanisms while also providing glucose as an energy substrate. We hypothesized that this approach would increase the acute pH modulation effect allowing the identification of aggressive cancer. Methods Using a 9.4 T MRI scanner, CEST spectra were acquired sensitive to pHi using amine/amide concentration independent detection (AACID). Twelve mice were scanned approximately 11 ± 1 days after implanting 105 U87 human glioblastoma multiforme cells in the brain, before and after intraperitoneal injection of a combination of five drugs (quercetin, cariporide, dichloroacetate, acetazolamide, and pantoprazole) with and without glucose. Results Two hours after combination drug injection there was a significant 0.1 ± 0.03 increase in tumor AACID value corresponding to a 0.4 decrease in pHi. After injecting the drug combination with glucose the AACID value increased by 0.18 ± 0.03 corresponding to a 0.72 decrease in pHi. AACID values were also slightly increased in contralateral tissue. Conclusions The combined drug treatment with glucose produced a large acute CEST MRI contrast indicating tumor acidification, which could be used to help localize brain cancer and monitor tumor response to chemotherapy.Keywords
Funding Information
- Ontario Institute of Cancer Research (OICR) Smarter Imaging Program (Grant Number 00807)
- the Canadian Institutes of Health Research
This publication has 67 references indexed in Scilit:
- Ion transporters in brain endothelial cells that contribute to formation of brain interstitial fluidPflügers Archiv - European Journal of Physiology, 2013
- Pharmacokinetics and Pharmacodynamics of the Proton Pump InhibitorsJournal of Neurogastroenterology and Motility, 2013
- Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs – an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer researchJournal of Translational Medicine, 2013
- Blocking the Na+/H+ exchanger 1 with cariporide (HOE642) reduces the hypoxia-induced invasion of human tongue squamous cell carcinomaInternational Journal of Oral and Maxillofacial Surgery, 2012
- Cotreatment with dichloroacetate and omeprazole exhibits a synergistic antiproliferative effect on malignant tumorsOncology Letters, 2012
- Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategyJournal of Experimental & Clinical Cancer Research, 2010
- Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experimentsMagnetic Resonance in Medicine, 2009
- Proton Pump Inhibitors Induce Apoptosis of Human B-Cell Tumors through a Caspase-Independent Mechanism Involving Reactive Oxygen SpeciesCancer Research, 2007
- Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapyProceedings of the National Academy of Sciences, 2007
- Structural and functional analysis of the Na+/H+ exchangerBiochemical Journal, 2007